GlassScriptPhysician profile
Geeta Kurra
NPI 1518035369
$76,410.85
in general payments reported to CMS, 2019-2025
88 companies · $34K in 2025
The $34K reported for 2025 was more than what 95% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,948 · 2020: $1,571 · 2021: $1,413 · 2022: $4,196 · 2023: $21K · 2024: $13K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Food and Beverage: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,830 · Travel and Lodging: $6,052 · Honoraria: $1,200 · Education: $159 · Gift: $19.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,105.00 |
| Food and Beverage | $14,917.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,830.00 |
| Travel and Lodging | $6,051.61 |
| Honoraria | $1,200.00 |
| Education | $158.81 |
| Gift | $19.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22,793.01 | 2019-2025 | Enhertu, Datroway, Vanflyta |
| Astrazeneca Pharmaceuticals LP | $8,051.99 | 2019-2025 | Imfinzi, Calquence, Enhertu |
| Jazz Pharmaceuticals INC. | $7,250.56 | 2020-2025 | |
| Avyxa Pharma, LLC | $3,879.09 | 2025 | |
| Geron Corporation | $3,147.24 | 2025 | Imetelstat, Rytelo |
| Janssen Biotech, INC. | $2,738.31 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Onmark, INC. | $2,670.51 | 2025 | |
| Abbvie INC. | $2,539.09 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $2,264.99 | 2019-2025 | Fruzaqla, Ninlaro, Iclusig |
| Pfizer INC. | $2,110.73 | 2019-2025 | |
| Seagen INC. | $1,577.01 | 2019-2023 | Padcev, Tukysa |
| Springworks Therapeutics, INC. | $1,561.92 | 2024-2025 | Ogsiveo, Gomekli |
| E.R. Squibb & Sons, L.L.C. | $1,300.39 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Novartis Pharmaceuticals Corporation | $1,204.06 | 2019-2025 | |
| Genentech USA, INC. | $1,172.08 | 2019-2025 | Polivy, Lunsumio, Tecentriq |
Show all 88 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,133.52 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Gilead Sciences, INC. | $1,083.99 | 2019-2025 | Trodelvy |
| Beigene USA, INC. | $813.41 | 2023-2025 | Brukinsa |
| Amgen INC. | $503.68 | 2019-2023 | Kyprolis, Blincyto |
| Eisai INC. | $488.89 | 2019-2025 | |
| Celgene Corporation | $480.88 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Genzyme Corporation | $479.81 | 2019-2025 | |
| Astellas Pharma US INC | $447.66 | 2019-2025 | Padcev, Vyloy, Xtandi |
| Incyte Corporation | $443.30 | 2019-2025 | Jakafi, Zynyz, Monjuvi |
| Cardinal Health 110 LLC | $400.00 | 2025 | |
| Glaxosmithkline, LLC. | $348.62 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Ipsen Biopharmaceuticals, INC | $310.05 | 2019-2025 | Onivyde, Tazverik, Somatuline Depot |
| Lilly USA, LLC | $268.99 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Janssen Pharmaceuticals, INC | $255.47 | 2019-2023 | Xarelto |
| Sobi, INC | $255.30 | 2023-2025 | |
| Exelixis INC. | $249.61 | 2020-2025 | Cabometyx |
| Puma Biotechnology, INC. | $249.26 | 2019-2025 | Nerlynx |
| Rigel Pharmaceuticals, INC. | $237.77 | 2020-2025 | Rezlidhia, Tavalisse, Gavreto |
| Array Biopharma INC | $199.97 | 2024-2025 | Braftovi, Mektovi, Lorbrena |
| Bayer Healthcare Pharmaceuticals INC. | $192.63 | 2019-2025 | |
| Adaptive Biotechnologies Corporation | $184.74 | 2024-2025 | Clonoseq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.60 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $150.35 | 2021-2024 | Libtayo |
| Sumitomo Pharma America, INC. | $145.11 | 2023-2025 | Orgovyx |
| Alexion Pharmaceuticals, INC. | $143.55 | 2020-2025 | Ultomiris |
| Deciphera Pharmaceuticals INC. | $130.50 | 2023-2025 | Qinlock, Romvimza |
| Pharmaessentia USA Corporation | $124.30 | 2023-2025 | Besremi |
| Tempus Ai, INC | $122.19 | 2024-2025 | Xt Cdx |
| Acrotech Biopharma INC. | $109.72 | 2022-2025 | Beleodaq |
| Aveo Pharmaceuticals, INC. | $106.36 | 2022-2025 | |
| Adc Therapeutics America, INC. | $95.83 | 2022-2025 | |
| Ekos Corporation | $93.33 | 2019 | |
| Pharmacosmos Therapeutics INC. | $93.04 | 2023-2025 | Monoferric |
| Caris Mpi, INC. | $90.58 | 2025 | Mi Cancer Seek |
| Sirtex Medical INC | $86.26 | 2023 | Sir-Spheres Microspheres |
| Beone Medicines USA, INC. | $84.35 | 2025 | Brukinsa, Tevimbra |
| Pharmacyclics LLC, An Abbvie Company | $84.09 | 2019-2023 | Imbruvica |
| Tactile Systems Technology INC | $80.03 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Emd Serono, INC. | $72.43 | 2019-2024 | |
| Blueprint Medicines Corporation | $70.23 | 2022-2025 | Ayvakit |
| Syndax Pharmaceuticals, INC. | $64.40 | 2025 | |
| Stemline Therapeutics INC. | $56.66 | 2024-2025 | Orserdu |
| Tesaro, INC. | $54.15 | 2019 | |
| Epizyme, INC. | $54.13 | 2020-2021 | |
| Morphosys, US INC. | $51.06 | 2021-2023 | Monjuvi |
| Amneal Pharmaceuticals LLC | $48.96 | 2023-2025 | Avastin, Alymsys |
| Iovance Biotherapeutics, INC. | $47.44 | 2025 | Amtagvi |
| Servier Pharmaceuticals LLC | $46.67 | 2024-2025 | |
| Mirati Therapeutics, INC. | $44.56 | 2023-2024 | Krazati |
| Cardinal Health 414 LLC | $44.33 | 2023 | |
| Azurity Pharmaceuticals, INC. | $41.99 | 2025 | Vivimusta, Danziten |
| Recordati_rare_diseases_inc. | $39.08 | 2023-2025 | Panhematin, Enjaymo |
| Dova Pharmaceuticals | $38.92 | 2019-2020 | |
| Global Blood Therapeutics, INC. | $37.64 | 2020-2022 | |
| Coherus Oncology, INC. | $36.51 | 2024 | |
| Emmaus Medical, INC. | $36.49 | 2020-2021 | |
| Kite Pharma, INC. | $27.77 | 2021-2023 | Yescarta |
| Stryker Corporation | $26.01 | 2025 | Optablate |
| Mayne Pharma Commercial LLC | $25.55 | 2022 | |
| Foundation Medicine, INC. | $25.29 | 2020-2021 | |
| Myovant Sciences INC. | $24.93 | 2022 | |
| Accord Healthcare, INC. | $24.20 | 2025 | |
| Acceleron Pharma, INC. | $23.04 | 2021 | |
| Telix Pharmaceuticals | $22.88 | 2023 | Illuccix |
| Alnylam Pharmaceuticals INC. | $22.70 | 2024 | Givlaari |
| Aurobindo Pharma USA, INC. | $18.48 | 2019 | |
| Clovis Oncology, INC. | $16.88 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $16.79 | 2024 | Trelstar |
| Secura Bio, INC. | $16.34 | 2020 | |
| Novo Nordisk INC | $15.84 | 2022 | |
| Fortovia Therapeutics, INC. | $15.22 | 2019 | |
| Kyowa Kirin, INC. | $13.82 | 2020 | |
| Sysmex Inostics INC | $8.74 | 2019 |
Drugs and devices associated with these payments
Enhertu $16KZepzelca $7,180Imfinzi $5,008Imetelstat $2,333Fruzaqla $2,175Elahere $2,134Tecvayli $2,087Calquence $1,783Ogsiveo $1,540Padcev $1,515Datroway $1,216Brukinsa $878Rytelo $814Trodelvy $736Vanflyta $673Keytruda $664Opdivo $385Lenvima $322Venclexta $286Kisqali $276Lynparza $270Orgovyx $243Darzalex $239Polivy $236Tukysa $235Onivyde $229Reblozyl $229Braftovi $221Vonjo $217Xtandi $202Mektovi $200Cabometyx $189Clonoseq $185Talvey $179Ibrance $177Scemblix $169Welireg $166Rezlidhia $160Tavalisse $160Talzenna $158Imbruvica $155Epkinly $155Opdualag $152Elrexfio $148Zejula $147Jemperli $147Qinlock $131Lunsumio $129Verzenio $125Lorbrena $124Besremi $124Avastin $114Pluvicto $113Libtayo $112Sarclisa $110Tecentriq $109Inlyta $107Ojjaara $105Jakafi $102Jaypirca $102Gavreto $102Bosulif $101Columvi $99.22Xt Cdx $97.92Xofigo $96.15Nubeqa $96.15Adcetris $95.52Monoferric $93.04Ultomiris $91.33Mi Cancer Seek $90.58Pomalyst $86.76Sir-Spheres Microspheres $86.26Fotivda $85.71Krazati $85.04Entre Plus $80.03Flexitouch Plus $80.03Rybrevant $79.43Beleodaq $77.80Enjaymo $76.02Erleada $73.76Nerlynx $72.83Promacta $72.57Kyprolis $70.94Vyloy $62.73Tazverik $60.11Lutathera $56.73Orserdu $56.66Romvimza $56.23Phesgo $52.94Monjuvi $52.89Ayvakit $52.18Amtagvi $47.44Retevmo $47.27Ninlaro $46.91Illuccix $45.76Oxbryta $44.89Comirnaty $44.80Alecensa $43.54Akeega $40.82Injectafer $39.92
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geeta Kurra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.